You have read all your free articles, to continue reading subscribe to read the rest of this content.
As a precautionary measure, in the continuous efforts to limit the spreading of the COVID-19 outbreak, and to shelter patients as well as healthcare staff, external personnel are given restricted access to hospitals, which consequently affects monitoring, auditing and inspections of ongoing clinicalAlready a subscriber Login You have read all…
Researchers at Karolinska Institutet in Sweden have developed a new method, named COVseq, that can be used for surveillance of the viral genome on a massive scale at a low cost. For global surveillance of the SARS-CoV-2 genome, it is crucial to sequence and analyze many samples in a cost-effectivAlready…
Scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital has published a population-based study of the early spread of the SARS-Cov-2 virus, causing COVID-19 disease, in Iceland. The aim of the study was to provide a as comprehensive view as possiblAlready a subscriber Login You…
Valneva SE has announced the initiation of a Phase 1/2 clinical study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001 leverages the manufacturing platform of Valneva’s licensed Japanese encephalitis vaccine, IXIARO and is the first publicly announced inactivated vacAlready a subscriber Login You have read all your free articles,…
